| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 34.37▲ | 34.39▲ | 34.39▲ | 34.58▼ | 34.74▼ |
| MA10 | 34.58▲ | 34.73▲ | 34.73▲ | 34.46▼ | 35.25▼ |
| MA20 | 35.06▼ | 35.10▼ | 35.10▼ | 34.85▼ | 35.03▼ |
| MA50 | 35.33▼ | 35.54▼ | 35.58▼ | 35.46▼ | 33.73▲ |
| MA100 | 35.75▼ | 35.51▼ | 35.43▼ | 35.01▼ | 34.52▼ |
| MA200 | 34.18▲ | 33.36▲ | 33.29▲ | 33.45▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.059▼ | -0.059▼ | -0.058▼ | -0.002▼ | -0.198▼ |
| RSI | 49.976▼ | 48.560▼ | 48.350▼ | 40.688▼ | 48.534▼ |
| STOCH | 16.622▼ | 16.666▼ | 16.666▼ | 46.222 | 20.725 |
| WILL %R | -45.238 | -45.238 | -45.238 | -88.049▼ | -86.761▼ |
| CCI | 9.157 | -3.618 | -3.618 | -91.645 | -102.473▼ |
| ▼ MACD | $DSMC MACD(12,26,9) Crossed Below Signal Line | Set Alert |
|
Thursday, November 06, 2025 03:59 AM
One of Only Nine Therapies Chosen for the Inaugural FDA Commissioner’s National Priority Voucher for E-cigarette or Vaping CessationConference Call Scheduled for 8:30 AM EST Today, November 6, 2025 ...
|
|
Monday, November 03, 2025 06:30 AM
Day Safety Update Submitted to FDA ORCA-OL Long-Term Safety Trial Successfully ConcludedDSMC Completes Final Review of Cytisinicline, Finds No Drug Safety Concerns SEATTLE and VANCOUVER, British ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 34.144 | 34.34 | 34.144 | 34.216 | 7,800 |
| 13/11/25 | 34.96 | 34.99 | 34.408 | 34.408 | 3,368 |
| 12/11/25 | 35.17 | 35.17 | 34.84 | 34.84 | 4,942 |
| 11/11/25 | 34.86 | 34.92 | 34.81 | 34.8538 | 2,532 |
| 10/11/25 | 34.4605 | 34.6468 | 34.34 | 34.589 | 5,608 |
| 07/11/25 | 34.254 | 34.4118 | 34.16 | 34.4118 | 6,604 |
| 06/11/25 | 34.45 | 34.45 | 34.06 | 34.077 | 2,300 |
| 05/11/25 | 34.23 | 34.63 | 34.18 | 34.57 | 24,878 |
| 04/11/25 | 34.02 | 34.30 | 34.02 | 34.1506 | 11,277 |
| 03/11/25 | 34.88 | 34.88 | 34.23 | 34.515 | 8,700 |
|
|
||||
|
|
||||
|
|